Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant

Antibody responses against the SARS-CoV-2 Spike protein correlate with protection against COVID-19. Serum neutralizing antibodies appear early after symptom onset following SARS-CoV-2 infection and can last for several months. Similarly, the messenger RNA vaccine, mRNA-1273, generates serum neutrali...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:medRxiv
Auteurs principaux: Edara, Venkata Viswanadh, Floyd, Katharine, Lai, Lilin, Gardner, Meredith, Hudson, William, Piantadosi, Anne, Waggoner, Jesse J., Babiker, Ahmed, Ahmed, Rafi, Xie, Xuping, Lokugamage, Kumari, Menachery, Vineet, Shi, Pei-Yong, Suthar, Mehul S.
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872377/
https://ncbi.nlm.nih.gov/pubmed/33564782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.02.02.21250799
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires